Review Article
The Use of Essential Oils and Their Isolated Compounds for the Treatment of Oral Candidiasis: A Literature Review
Table 3
In vitro antifungal activity of essential oils against Candida albicans strains.
| | Plant species | Source | Microorganism | MIC50% (μg/mL) | Score MIC | Ref |
| | Achillea millefolium | Leaves | C. albicans clinical strain | 625 | ++ | [3] | | Allium tuberosum Rottl. ex Spreng | Commercial Source | C. albicans CBS 562 | 500 | +++ | [19] | | | C. albicans clinical strain | 500 | +++ | | Anethum graveolens | Seeds | C. albicans ATCC (62342) | >2001 | − | [20] | | | Candida albicans clinical strain | >2001 | − | | Bursera morelensis | Leaves | C. albicans clinical strain | 125 | +++ | [21] | | Cinnamomum burmannii | Commercial source | C. albicans ATCC 28366 | 1000 | ++ | [22] | | Cinnamomum cassia | Bark | C. albicans ATCC 76485 | 64 | ++++ | [23] | | | C. albicans C01-C11 | 64 | ++++ | | Cinnamomum zeylanicum | Commercial source | C. albicans ATCC 76845 | 312.5 | +++ | [24] | | Cinnamomum zeylanicum | Commercial source | C. albicans ATCC 76485 | 312.5 | +++ | [25] | | | C. albicans ATCC 76645 | 312.5 | +++ | | | C. albicans clinical strain | 625 | ++ | | Cinnamomum zeylanicum Blume | Commercial source | C. albicans ATCC 40277 | 312.5 | +++ | [14] | | | C. albicans clinical strain | 312.5 | +++ | | Cinnamomum zeylanicum Blume | Commercial source | C. albicans CBS 562 | 250 | +++ | [26] | | | C. albicans ATCC 60193 | 250 | +++ | | | C. albicans ATCC 90029 | 125 | +++ | | | C. albicans LM01 | 250 | +++ | | | C. albicans LM03 | 250 | +++ | | | C. albicans LM04 | 500 | +++ | | Coriandrum sativum | Commercial source | C. albicans CBS 562 | 15.0 | ++++ | [19] | | | C. albicans clinical strain 3 A5 | 31.0 | ++++ | | Coriandrum sativum L. | Leaves | C. albicans CBS 562 | 15.6 | ++++ | [27] | | Cuminum cyminum | Seeds | C. albicans ATCC62342 | >2001 | − | [20] | | | C. albicans clinical strain | >2001 | − | | Curcuma longa L. | Rhizomes | C. albicans Clinical strain | 625 | ++ | [3] | | Laurus nobilis L. | Commercial source | C. albicans ATCC 60193 | 250 | +++ | [28] | | Melaleuca alternifólia | Commercial source | C. albicans ATCC 289065 | >2001 | − | [29] | | | C. albicans ATCC 40277 | >2001 | − | | Melaleuca alternifolia | Commercial source | C. albicans ATCC 18804 | 1950 | + | [30] | | Melaleuca alternifolia | Commercial source | C. albicans clinical strain | >2001 | − | [31] | | Pimpinella anisum | Seeds | C. albicans ATCC 62342 | >2001 | − | [20] | | | Candida albicans clinical strain | >2001 | − | | Ocotea odorifera | Commercial source | C. albicans ATCC-90028 | >2001 | − | [24] | | | C. albicans ATCC-76615 | >2001 | − | | | C. albicans ATCC-76645 | >2001 | − | | | C. albicans ATCC-76485 | >2001 | − | | | C. albicans clinical strain | >2001 | − | | Rosmarinus officinalis | Commercial source | C. albicans, ATCC 289065 | 562,5 | ++ | [29] | | | C. albicans ATCC 40277 | <2001 | − | | Rosmarinus officinalis L. | Commercial source | C. albicans ATCC-90028 | >2001 | − | [24] | | | C. albicans ATCC-76615 | >2001 | − | | | C. albicans ATCC-76645 | >2001 | − | | | C. albicans ATCC-76485 | >2001 | − | | | C. albicans clinical strain | >2001 | − | | Santolina chamaecyparissus | Commercial source | C. albicans CBS 562 | 1000 | ++ | [19] | | | C. albicans clinical strain | >2001 | − | | Satureja hortensis L. | Leaves | C. albicans Clinical strain | 200 | +++ | [32] |
|
|
nt (not tested); comparative MIC values (μg/mL): (++++) <100; (+++) 100 to 500; (++) 501 to 1000; (+) >1001 to 2000; (−) >2001.
|
